← FDA Drug Approvals (Drugs@FDA)

GEFITINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2025-05-16

Drug application

FDA Application #

ANDA211826

Application type

Abbreviated New Drug Application (Generic)

Brand name

GEFITINIB

Generic name

Gefitinib

Active ingredients

GEFITINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

CIPLA

First approval

2025-05-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown